Results 151 to 160 of about 53,162 (283)
Bile duct loss on liver biopsy predicts future liver‐related events in early‐stage primary biliary cholangitis, even in patients with preserved liver function. This finding highlights the prognostic value of histological bile duct assessment at diagnosis and may guide early risk stratification and management decisions.
Taiki Okumura +15 more
wiley +1 more source
Introduction: Hepatitis B virus infection is a major public health problem worldwide. It is more infectious and more in Nigeria than the Human Immunodeficiency Virus (HIV).
Habibu B, Belonwu R, Ibrahim M
doaj
A novel monoclonal antibody targeting a conserved inner region of the hepatitis B virus envelope enables broad detection of immune escape variants. [PDF]
Chen Y +8 more
europepmc +1 more source
ABSTRACT Aim This study is aimed to evaluate the safety and outcomes of surgical resection in patients with hepatocellular carcinoma (HCC) treated with systemic therapy, address the therapeutic benefit, and identify candidates for surgery after systemic treatment.
Takamichi Ishii +16 more
wiley +1 more source
Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial. [PDF]
Tabataba Vakili S +19 more
europepmc +1 more source
Efficacy and predictors of pegylated-interferon in hepatitis B surface antigen seroclearance in immune active and inactive chronic hepatitis B patients. [PDF]
Han C +6 more
europepmc +1 more source
[Excretion of HBsAg in the HBsAg carrier].
S, Kashiwagi +4 more
openaire +1 more source
Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon. [PDF]
Dong J +16 more
europepmc +1 more source

